The investment seeks to provide long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapValue
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LOGSX | 24.22 | 0.24 | +1.00% |
| Live Oak Health Sciences | |||
| SFLNX | 33.72 | 0.28 | +0.84% |
| Schwab Fundamental US Large Company Idx | |||
| DREVX | 19.77 | 0.10 | +0.51% |
| BNY Mellon Large Cap Securities Inc | |||
| ESGMX | 21.87 | 0.11 | +0.51% |
| Mirova Global Megatrends A | |||
| IACIX | 11.67 | 0.05 | +0.43% |
| VY® American Century Sm-Mid Cp Val I | |||
A.I.dvisor indicates that over the last year, RVACX has been closely correlated with VEVYX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVACX jumps, then VEVYX could also see price increases.
| Ticker / NAME | Correlation To RVACX | 1D Price Change % | ||
|---|---|---|---|---|
| RVACX | 100% | +0.77% | ||
| VEVYX - RVACX | 93% Closely correlated | +0.63% | ||
| VMVIX - RVACX | 83% Closely correlated | +0.52% | ||
| VMVAX - RVACX | 83% Closely correlated | +0.52% | ||
| MVCAX - RVACX | 80% Closely correlated | +0.58% | ||
| JVMIX - RVACX | 76% Closely correlated | +0.59% | ||
More | ||||